1. Discuss the FDA 503B Draft Interim and Final Guidance documents.
2. Differentiate the elements of 21 CFR 211 that are applied to a 503B as compared to traditional pharmaceutical manufacturers.
3. Describe what would be expected of a 503B outsourcer during an FDA inspection.
- Provider:TRC Healthcare
- Activity Link: https://www.criticalpoint.info/activities
- Start Date: 2022-05-15 05:00:00
- End Date: 2022-05-15 05:00:00
- Credit Details: Pharmacy: 2.0 hours
- Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Yes
- Measured Outcome: Learner Knowledge
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest